回复hoohau发表于：2020/8/18 21:14:01悬赏金额：
20积分 状态：
未解决
【序号】：1
【作者】：Aayam Lamichhane
【题名】：The mucosal immune system for vaccinedevelopment
【期刊】：Vaccine
【年、卷、期、起止页码】：Volume 32, Issue 49, 20November 2014, Pages 6711–6723
【全文链接】：http://www.sciencedirect.com/science/article/pii/S0264410X1401370X
【序号】：2
【作者】：Jan T Poolman, Carla CAM Peeters, and GermiePJM van den Dobbelsteen
【题名】：The history of pneumococcal conjugate vaccinedevelopment: dose selection
【期刊】：Expert Review of Vaccines
【年、卷、期、起止页码】：December 2013, Vol. 12,No. 12 , Pages 1379-1394
【全文链接】：http://informahealthcare.com/doi/abs/10.1586/14760584.2013.852475
【序号】：3
【作者】：Ruth Mitchell, Johannes Trück, and Andrew JPollard
【题名】：Use of the 13-valent pneumococcal conjugatevaccine in children and adolescents aged 6 – 17 years
【期刊】：Expert Opinion on Biological Therapy
【年、卷、期、起止页码】：October 2013, Vol. 13,No. 10 , Pages 1451-1465
【全文链接】：http://informahealthcare.com/doi/abs/10.1517/14712598.2013.824419
【序号】：4
【作者】：Simon Athlin
【题名】：Association between Serotype-Specific AntibodyResponse and Serotype Characteristics in Patients with Pneumococcal Pneumonia,with Special Reference to Degree of Encapsulation and Invasive Potential
【期刊】：Clinical and Vaccine Immunology
【年、卷、期、起止页码】：November 2014 vol. 21no. 11 1541-1549
【全文链接】：http://cvi.asm.org/content/21/11/1541.abstract
【序号】：5
【作者】：William P Hausdorff, Bernard Hoet, Richard AAdegbola
【题名】：Predicting the impact of new pneumococcalconjugate vaccines: serotype composition is not enough
【期刊】：Expert Review of Vaccines
【全文链接】： http://informahealthcare.com/doi/abs/10.1586/14760584.2015.965160?src=recsys
您现在的位置：
